Strategic Partners A/S (CPH:STRAP)
615.00
-15.00 (-2.38%)
Oct 16, 2026, 10:22 AM CET
Strategic Partners Market Cap
Strategic Partners has a market cap or net worth of 25.65 million as of October 15, 2026. It is the 45,866th most valuable company in the world and the 127th biggest in Denmark. Its market cap has decreased by 28.65% in one year.
Market Cap
25.65M
Enterprise Value
9.12M
Revenue
304.00K
Global Rank
Country Rank
#127 Denmark
PE Ratio
19.77
ChartMarket Cap Chart
Since November 21, 2017, Strategic Partners's market cap has decreased from 1.59B to 25.65M, a decrease of -98.39%. That is a compound annual growth rate of -37.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 25.65M | -11.89% |
| Dec 30, 2025 | 29.11M | -15.40% |
| Dec 30, 2024 | 34.42M | -26.72% |
| Dec 29, 2023 | 46.96M | 51.14% |
| Dec 30, 2022 | 31.07M | -94.82% |
| Dec 30, 2021 | 599.78M | -74.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.13T |
| Genmab | 148.25B |
| Coloplast | 102.52B |
| Demant | 74.83B |
| Gubra | 4.77B |
| BioPorto | 507.49M |
| Pharma Equity Group | 97.22M |
| ViroGates | 71.01M |